Variation in the commensal urinary microbiome is associated with response to Bacillus Calmette-Guerin (BCG) immunotherapy in early stage urothelial bladder cancer

被引：0
|
作者：
Sweis, Randy [1 ]
Andolfi, Ciro [1 ]
Bloodworth, Jeffrey [1 ]
Golan, Shay [2 ]
Barashi, Nimrod [3 ]
Hill, Elle [1 ]
Werntz, Ryan [1 ]
Gajewski, Thomas [1 ]
Steinberg, Gary [4 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Rabin Med Ctr, Chicago, IL USA
[3] Univ Illinois, Chicago, IL USA
[4] NYU, Chicago, IL USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O67
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association of the commensal urinary microbiome with response to Bacillus Calmette-Guerin (BCG) immunotherapy in nonmuscle invasive bladder cancer.
    Sweis, Randy F.
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Werntz, Ryan P.
    Bloodworth, Jeffrey
    Steinberg, Gary D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [2] The commensal urinary microbiome as a predictor of response to Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle invasive bladder cancer
    Sweis, Randy F.
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Werntz, Ryan
    Bloodworth, Jeffrey
    Gajewski, Thomas
    Steinberg, Gary D.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder
    Kresowik, Timothy P.
    Griffith, Thomas S.
    [J]. IMMUNOTHERAPY, 2009, 1 (02) : 281 - 288
  • [4] FASL polymorphism is associated with response to bacillus Calmette-Guerin immunotherapy in bladder cancer
    Lima, Luis
    Ferreira, Jose A.
    Tavares, Ana
    Oliveira, Daniela
    Morais, Antonio
    Videira, Paula A.
    Medeiros, Rui
    Santos, Lucio
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 44.e1 - 44.e7
  • [5] Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: Review of complications and their treatment
    Paterson, DL
    Patel, A
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1998, 68 (05): : 340 - 344
  • [6] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
    Hugar, Lee A.
    Gilbert, Scott M.
    Sexton, Wade J.
    Kamat, Ashish M.
    Li, Roger
    [J]. CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
  • [7] PRICING AND REIMBURSEMENT ANALYSIS OF BACILLUS CALMETTE-GUERIN (BCG) IMMUNOTHERAPY FOR BLADDER CANCER
    Bekcic, S.
    Mitrovic, I
    Baltezarevic, D.
    Radojevic, V
    Samardzic, J.
    Milenkovic, V
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A654 - A654
  • [8] Recombinant bacillus Calmette-Guerin in urothelial bladder cancer immunotherapy: current strategies
    Wang, Yonghua
    Yang, Meng
    Yu, Qinchao
    Yu, Lun
    Shao, Shixiu
    Wang, Xinsheng
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 85 - 93
  • [9] Immunotherapy With Bacillus Calmette-Guerin (BCG) in a 16-Year-Old With Urothelial Bladder Carcinoma
    Martinez-Thomas, Jose M.
    Galicia-Belaunzaran, Luis F.
    Merayo-Chalico, Claudio E.
    Palatchi, Joseph
    Carlos Angulo-Lozano, Juan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [10] Bacillus Calmette-Guerin (BCG)-induced balanitis following intravesical immunotherapy for urothelial cancer
    Kumar, Santosh
    Thummala, Yashaswi
    Parmar, Kalpesh Mahesh
    Chandna, Abhishek
    [J]. BMJ CASE REPORTS, 2021, 14 (04)
12345